ArticleBone marrow transplantation2023

Chidamide maintenance therapy in high-risk T-ALL/T-LBL after allo-HSCT: a prospective, single-center, single-arm study.

Wenwen Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.